BSE and vCJD cause disturbance to uric acid levels
- PMID: 15473996
- DOI: 10.1016/j.expneurol.2004.07.002
BSE and vCJD cause disturbance to uric acid levels
Abstract
Bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) are two new members of the family of neurodegenerative conditions termed prion diseases. Oxidative damage has been shown to occur in prion diseases and is potentially responsible for the rapid neurodegeneration that is central to the pathogenesis of these diseases. An important nonenzymatic antioxidant in the brain is uric acid. Analysis of uric acid in the brain and cerebrospinal fluid (CSF) of cases of BSE and CJD showed a specific reduction in CSF levels for both BSE and variant CJD, but not sporadic CJD. Further studies based on cell culture experiments suggested that uric acid in the brain was produced by microglia. Uric acid was also shown to inhibit neurotoxicity of a prion protein peptide, production of the abnormal prion protein isoform (PrP(Sc)) by infected cells, and polymerization of recombinant prion protein. These findings suggest that changes in uric acid may aid differential diagnosis of vCJD. Uric acid could be used to inhibit cell death or PrP(Sc) formation in prion disease.
Similar articles
-
Guinea Pig Prion Protein Supports Rapid Propagation of Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease Prions.J Virol. 2016 Oct 14;90(21):9558-9569. doi: 10.1128/JVI.01106-16. Print 2016 Nov 1. J Virol. 2016. PMID: 27440899 Free PMC article.
-
Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3065-70. doi: 10.1073/pnas.0305777101. Epub 2004 Feb 17. Proc Natl Acad Sci U S A. 2004. PMID: 14970340 Free PMC article.
-
Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.J Neuropathol Exp Neurol. 2006 Oct;65(10):964-75. doi: 10.1097/01.jnen.0000235120.59935.f5. J Neuropathol Exp Neurol. 2006. PMID: 17021401
-
PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease.Biomolecules. 2020 Mar 5;10(3):405. doi: 10.3390/biom10030405. Biomolecules. 2020. PMID: 32151109 Free PMC article. Review.
-
Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis.Microsc Res Tech. 2000 Jul 1;50(1):2-9. doi: 10.1002/1097-0029(20000701)50:1<2::AID-JEMT2>3.0.CO;2-C. Microsc Res Tech. 2000. PMID: 10871542 Review.
Cited by
-
Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice.Neuromolecular Med. 2007;9(4):315-23. doi: 10.1007/s12017-007-8010-1. Epub 2007 Aug 10. Neuromolecular Med. 2007. PMID: 17999205
-
Mechanistic insights into the cure of prion disease by novel antiprion compounds.J Virol. 2007 Oct;81(19):10729-41. doi: 10.1128/JVI.01075-07. Epub 2007 Jul 25. J Virol. 2007. PMID: 17652397 Free PMC article.
-
The molecular epidemiology of variant CJD.Int J Mol Epidemiol Genet. 2011 Aug 30;2(3):217-27. Epub 2011 Jun 3. Int J Mol Epidemiol Genet. 2011. PMID: 21915360 Free PMC article.
-
Genomic and post-genomic analyses of human prion diseases.Genome Med. 2009 Jun 22;1(6):63. doi: 10.1186/gm63. Genome Med. 2009. PMID: 19566915 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials